Company Filing History:

15 out of 692

Sterling Drug Inc.

patents

1 out of 206

Sterling Winthrop Inc.

Years Active: 1976-1998

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5817651 - 3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles (1998-10-06),

2. 5324737 - 3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles (1994-06-28),

3. 5068234 - 3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles (1991-11-26),

4. 4861791 - Dihydro-oxazolyl substituted-phenyl-aliphatic lower alkyl and their use (1989-08-29),

5. 4857539 - Heterocyclic substituted-phenoxyalkylisoxazoles as antiviral useful (1989-08-15),

6. 4431651 - 2-Pyridinones and their use as cardiotonic agents (1984-02-14),

7. 4268678 - 4-(Arylaliphatic)isoxazoles (1981-05-19),

8. 4261928 - 2-Benzoyl-8-(2-chloro-4-methoxyphenoxy)-1-phenyl-1-octanone (1981-04-14),

9. 4234725 - 4-[6-(2-Chloro-4-methoxyphenoxy)hexyl] (1980-11-18),

10. 4232161 - 4-[6-( (1980-11-04),

11. 4209526 - Antiviral arylenedioxyalkyl substituted pyrazoles (1980-06-24),

12. 4171365 - Antiviral aryloxyalkylpyrazoles (1979-10-16),

13. 4096280 - Arylenedioxy-bis-diketones (1978-06-20),

14. 4055588 - Tetra-(low (1977-10-25),

15. 4008239 - Preparation of 4-(3-nitrophenyl)pyridine (1977-02-15),

Title: Innovations and Contributions of Inventor Philip M. Carabateas

Introduction

Philip M. Carabateas is a distinguished inventor based in Schodack, NY, best known for his contributions to the pharmaceutical field. With a remarkable portfolio of 17 patents, he has significantly impacted the development of innovative therapeutic agents.

Latest Patents

Among his latest patents are developments related to 3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles. These compounds, specifically the 2-R2-R4-substituted and 3-R3-CO-1-(C-attached-N-heteryl)-(Alk)n-1H-indoles, are recognized for their potential use as analgesic, anti-rheumatic, anti-inflammatory, or anti-glaucoma agents. His work in this area highlights his commitment to addressing critical health issues through innovative chemical solutions.

Career Highlights

Throughout his career, Philip has worked with prominent organizations, including Sterling Drug Inc. and Sterling Winthrop Inc. His tenure in these companies has allowed him to refine his inventive skills and apply them to real-world pharmaceutical challenges. His innovative mindset and dedication continue to shape the future of therapeutic drug development.

Collaborations

Philip has collaborated with notable professionals in the industry, including Guy D. Diana and Thomas E. D'Ambra. These collaborations exemplify his ability to work alongside other talented individuals to advance the understanding and application of his inventions.

Conclusion

Philip M. Carabateas stands out as a prolific inventor in the realm of pharmaceuticals, with a legacy built on innovation and collaboration. His work continues to inspire new approaches to the treatment of various medical conditions, making significant contributions to the field and improving the quality of life for many patients.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.

For the Inventor, By the Inventor

Philip M Carabateas

Company Filing History:

Years Active: 1976-1998